Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities
Top Cited Papers
Open Access
- 1 July 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (1) , 201-210
- https://doi.org/10.1182/blood-2006-11-056168
Abstract
CD137 is a member of the TNFR-family with costimulatory function. Here we show that it also has many favorable characteristics as a surrogate marker for antigen-specific activation of human CD8+ T cells. Although undetectable on unstimulated CD8+ T cells, it is uniformly up-regulated 24 hours after stimulation on virtually all responding cells regardless of differentiation stage or profile of cytokine secretion, which circumvents limitations of current surrogate markers for defining the repertoire of responding cells based on only individual functions. Antibody-labeled responding CD137+ cells can be easily and efficiently isolated by flow sorting or magnetic beads to substantially enrich antigen-specific T cells. To test this approach for epitope discovery, we examined in vitro priming of naive T cells from healthy donors to Wilms tumor antigen 1 (WT1), a protein overexpressed in various malignancies. Two overlapping pentadecamers were identified as immunogenic, and further analysis defined WT1(286–293) as the minimal amino acid sequence and HLA-Cw07 as the HLA restriction element. In conclusion, this approach appears to be an efficient and sensitive in vitro technique to rapidly identify and isolate antigen-specific CD8+ T cells present at low frequencies and displaying heterogeneous functional profiles, and does not require prior knowledge of the specific epitopes recognized or the HLA-restricting elements.Keywords
This publication has 44 references indexed in Scilit:
- Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primatesThe Journal of Experimental Medicine, 2006
- Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancerTrends in Immunology, 2005
- Direct access to CD4+ T cells specific for defined antigens according to CD154 expressionNature Medicine, 2005
- Antigen-specific cellular immunotherapy of leukemiaLeukemia, 2005
- Cellular immune selection with hepatitis C virus persistence in humansThe Journal of Experimental Medicine, 2005
- Wilms' tumour gene 1 (WT1) in human neoplasiaLeukemia, 2005
- Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survivalTransplant International, 2004
- Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survivalTransplant International, 2004
- Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2004
- Towards patient‐specific tumor antigen selection for vaccinationImmunological Reviews, 2002